Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22
oral glp-1 agonist for type 2 diabetes receptor agonists individualized treatment of mellitus Eli Lilly strikes Zepbound $20 - $30 Quantity:1 Month Supply (90 Count)
Eli Lilly strikes Zepbound deal with Ro, amid questions on compounded GLP-1s
For more information, see KFF’s policy watch on rising Medicare spending on Ozempic and other GLP-1 Drugs
$20 - $30
Quantity:1 Month Supply (90 Count)
Metabolic syndrome is a cluster of conditions-increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels-that occur together, increasing your risk of heart disease, stroke, and type 2 diabetes
US$ 29.77
US$ 24.81
US$ 26.68
